Vimarsana
Biggest News Aggregation in the World

Page 17 - Sheet Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sheet Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sheet Data Today - Breaking & Trending Today

Hurco Companies, Inc.: Hurco Reports Second Quarter Results for Fiscal Year 2023 - Vimarsana News

Hurco Companies, Inc.: Hurco Reports Second Quarter Results for Fiscal Year 2023

INDIANAPOLIS, June 02, 2023 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the second fiscal quarter ended April 30, 2023. Hurco recorded net income of $377,000,

AirSculpt Technologies Announces First Quarter 2023 Results, Reaffirms 2023 Guidance and Announces London Opening - Vimarsana News

AirSculpt Technologies Announces First Quarter 2023 Results, Reaffirms 2023 Guidance and Announces London Opening

MIAMI BEACH, Fla., May 12, 2023 -- AirSculpt Technologies, Inc. , a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2023.... | May 12, 2023

Telesis Bio Reports First Quarter 2023 Financial Results - Vimarsana News

Telesis Bio Reports First Quarter 2023 Financial Results

-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and

Telesis Bio Reports First Quarter 2023 Financial Results - Vimarsana News

Telesis Bio Reports First Quarter 2023 Financial Results

-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology... | June 15, 2023

4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights - Vimarsana News

4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights

Presented positive interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial for wet age-related macular degeneration at the 2023 ARVO Annual MeetingOn track for completion of enrollment... | May 10, 2023